# A Vaccine Study for High Risk Cancers

> **NCT00944580** · PHASE1 · WITHDRAWN · sponsor: **Penn State University**

## Conditions studied

- Neuroblastoma
- Rhabdomyosarcoma
- Osteogenic Sarcoma

## Interventions

- **BIOLOGICAL:** MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine

## Key facts

- **NCT ID:** NCT00944580
- **Lead sponsor:** Penn State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unexpectedly low screening results leading to poor accrual
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944580, "A Vaccine Study for High Risk Cancers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00944580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*